Novo Nordisk A/S (NVO)
37.32
-0.08
(-0.21%)
USD |
NYSE |
Oct 02, 16:00
37.31
-0.01
(-0.03%)
After-Hours: 20:00
Novo Nordisk Gross Profit Margin (Quarterly) : 78.21% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 78.21% |
| March 31, 2026 | 85.96% |
| December 31, 2025 | 80.86% |
| September 30, 2025 | 76.12% |
| June 30, 2025 | 83.29% |
| March 31, 2025 | 83.49% |
| December 31, 2024 | 84.80% |
| September 30, 2024 | 84.14% |
| June 30, 2024 | 84.90% |
| March 31, 2024 | 84.83% |
| December 31, 2023 | 84.80% |
| September 30, 2023 | 83.46% |
| June 30, 2023 | 85.53% |
| March 31, 2023 | 84.67% |
| December 31, 2022 | 82.82% |
| September 30, 2022 | 84.20% |
| June 30, 2022 | 85.29% |
| March 31, 2022 | 83.54% |
| December 31, 2021 | 83.72% |
| September 30, 2021 | 82.99% |
| June 30, 2021 | 83.21% |
| March 31, 2021 | 82.81% |
| December 31, 2020 | 82.52% |
| September 30, 2020 | 83.33% |
| June 30, 2020 | 84.10% |
| Date | Value |
|---|---|
| March 31, 2020 | 84.10% |
| December 31, 2019 | 83.24% |
| September 30, 2019 | 83.24% |
| June 30, 2019 | 83.86% |
| March 31, 2019 | 83.84% |
| December 31, 2018 | 84.35% |
| September 30, 2018 | 84.10% |
| June 30, 2018 | 84.12% |
| March 31, 2018 | 84.42% |
| December 31, 2017 | 83.21% |
| September 30, 2017 | 83.95% |
| June 30, 2017 | 84.60% |
| March 31, 2017 | 85.06% |
| December 31, 2016 | 83.37% |
| September 30, 2016 | 85.52% |
| June 30, 2016 | 85.27% |
| March 31, 2016 | 84.44% |
| December 31, 2015 | 84.04% |
| September 30, 2015 | 85.64% |
| June 30, 2015 | 85.74% |
| March 31, 2015 | 84.63% |
| December 31, 2014 | 83.73% |
| September 30, 2014 | 84.60% |
| June 30, 2014 | 83.03% |
| March 31, 2014 | 82.96% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 76.09% |
| GSK Plc | 75.05% |
| Johnson & Johnson | 68.73% |
| Eli Lilly & Co. | 85.78% |
| Merck & Co., Inc. | 71.51% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 61.11% |
| Return on Assets | 21.71% |
| Return on Invested Capital | 37.13% |
| Profit Margin (Quarterly) | 26.74% |
| Operating Margin (Quarterly) | 43.31% |
| Return on Net Operating Assets | 25.79% |